- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01942616
The Development of a Domestic Violence Perpetrator Collusion Measurement Tool
Media, Public Health, and Colluding With Murder: The Development of a Domestic Violence Perpetrator Collusion Measurement Tool.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim 1: To determine the impact of media "frames," "labeling," and "information inclusion" on "implicit collusion" with a DV perpetrator.
Hypotheses: Consumers exposed to media reports using "thematic frames" will be less likely to implicitly collude with perpetrators than those exposed to "episodic frames." Consumers exposed to DVH news stories labeled as "domestic violence" will be less likely to implicitly collude with perpetrators than consumers exposed to news stories labeled as "assault." Implicit collusion will correlate positively with the addition of non-relevant perpetrator "humanizing" characteristics. Consumers given negative information about the victim of DVH will be more likely to implicitly collude with the perpetrator than consumers given negative information about the perpetrator.
Aim 2: To determine how media portrayals of domestic violence impact descriptive and injunctive norms about domestic violence and, ultimately, drive implicit collusion with perpetrators.
Hypotheses: Controlling for individual pre-existing attitudes and social norms, consumers exposed to thematic frames or the label of DV will be less likely to shift their norms in a way that supports DV than those exposed to episodic frames or the label of assault. Consumers provided negative victim information or non-relevant characteristics that humanize the perpetrator will be more likely to shift their norms to accept DV.
Exploratory Aim: To identify racial/ethnic, gender, age, and regional differences in DV social norms.
Hypothesis: The media will differentially impact subpopulation DV attitudes, social norms and implicit collusion.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06519
- Yale University
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70118
- Loyola University New Orleans
-
-
Michigan
-
East Lansing, Michigan, United States, 48824
- Michigan State University
-
Lansing, Michigan, United States, 48913
- Michigan Department of Community Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Members of the public who are 18 years or older, who identify as White or African American or Hispanic.
Exclusion Criteria:
- Members of the public will be excluded if they are unable to read or understand English.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Condition 1
Each study arm contains different scenarios presented to the participant. Condition 1 is a Perpetrator Positive scenario. The content of the Condition 1 group is as follows: Framing: Episodic Labeling: DV label Extraneous Information: Perpetrator positive non relevant Victim/Perp Characteristic: Negative victim |
Condition 1 frames the event as episodic, labels the event as domestic violence, uses a positive description of the perpetrator, and a negative description of the victim.
|
Experimental: Condition 2
Each study arm contains different scenarios presented to the participant. Condition 2 is a Perpetrator Negative scenario. The content of the Condition 2 group is as follows: Framing: Thematic Labeling: Assault label Extraneous Information: Perpetrator neutral non relevant Victim/Perp Characteristic: Negative Perpetrator |
The condition 2 intervention/exposure frames the event as thematic, labels the event as assault, uses a neutral description of the perpetrator, and a negative description of the perpetrator.
|
Placebo Comparator: Condition 3
Each study arm contains different scenarios presented to the participant. The content of the Condition 3 group is as follows: Framing: Neither Labeling: No label Extraneous Information: None Victim/Perp Characteristic: None |
This intervention provides no details for the participant and is for comparison use in the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline on The Collusion Framing Subscale
Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
|
The scale will be developed based on the changes from baseline.
|
The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
|
Change from Baseline on The Collusion Labeling Subscale
Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
|
The scale will be developed based on the changes from baseline.
|
The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
|
Change from Baseline on The Collusion Extraneous Information Subscale
Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
|
The scale will be developed based on the changes from baseline.
|
The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
|
Change from Baseline on The Collusion Negative Characteristics Subscale
Time Frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
|
The scale will be developed based on the changes from baseline.
|
The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 0910005885
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intimate Partner Violence (IPV)
-
University of California, San DiegoBill and Melinda Gates Foundation; Population Council; International Planned...CompletedUnintended Pregnancy | Family Planning | Intimate Partner Violence (IPV)United States
-
University of California, San DiegoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedUnintended Pregnancy | Family Planning | Intimate Partner Violence (IPV)United States, Mexico
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDomestic Violence | Intimate Partner ViolenceUnited States
-
NMP Medical Research InstituteWarwick Research Services; Arsha Vidya Study Centre, Tamilnadu, IndiaCompletedDomestic Violence | Intimate Partner ViolenceIndia
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingIntimate Partner ViolenceUnited States
-
Johns Hopkins UniversityUniversity of Missouri-Columbia; Centers for Disease Control and PreventionCompletedIntimate Partner ViolenceUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedIntimate Partner ViolenceUnited States
-
Northeastern UniversityRhode Island HospitalCompleted
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Joanne KlevensUniversity of Michigan; The Community Health and Social Services Center, Inc.Completed
Clinical Trials on Condition 1: Perpetrator Positive
-
University of Colorado, BoulderNational Institute of Mental Health (NIMH)CompletedPhysical Activity | Affect
-
University of ManitobaEnrolling by invitationCardiovascular DiseasesCanada
-
Massachusetts General HospitalAmerican Foundation for Suicide PreventionCompletedMajor Depressive DisorderUnited States
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)CompletedOpioid Abuse (Disorder)United States
-
Northwestern UniversityUniversity of California, San FranciscoActive, not recruiting
-
University of ChicagoTerminated
-
University of Wisconsin, MilwaukeeTerminatedSocial Anxiety | Social Anxiety DisorderUnited States
-
American University of Beirut Medical CenterCompleted
-
Brown UniversityUniversity of California, Los Angeles; National Institute of Nursing Research... and other collaboratorsRecruiting